Shopping Cart
Remove All
Your shopping cart is currently empty
Prolgolimab (BCD-100) is an anti-PD-1 antibody used in melanoma research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $163 | - | In Stock | |
| 5 mg | $496 | - | In Stock | |
| 10 mg | $795 | - | In Stock | |
| 25 mg | $1,180 | - | In Stock | |
| 50 mg | $1,580 | - | In Stock |
| Description | Prolgolimab (BCD-100) is an anti-PD-1 antibody used in melanoma research. |
| In vitro | Prolgolimab is an inhibitor of PD-1. By blocking the interaction of PD-1 with ligands PD-L1 and PD-L2, Prolgolimab can enhance the anti-tumor response of T cells and thus shrink tumors. It can be used for cancer research such as melanoma, advanced non-squamous non-small cell lung cancer. |
| Synonyms | BCD-100, BCD100 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | PDCD1/PD-1/CD279 |
| Molecular Weight | 146.28 kDa |
| Cas No. | 2093956-19-3 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.